# Mount Sinai Innovation Partners

Mount Sinai Innovation Partners is a Venture Capital based in New York, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** ip.mountsinai.org
- **LinkedIn:** https://www.linkedin.com/company/mount-sinai-innovation-partners

## Regulatory record

- **Reports private funds:** No

## About

2023 in Review 904 Inventors Engaged 140 Technology Disclosures 268 Patent Filings From the Inventors Yaron Tomer, MD, Former Chief of the Division of Endocrinology, Diabetes and Bone Diseases at the Icahn School of Medicine at Mount Sinai’s Department of Medicine "Working with MSIP helped my research program on many levels. The team gave me advice

## Sectors

- Digital Health
- Healthcare Services
- AI/ML

## People

- Erik Lium — President

## Questions

### How is Mount Sinai Innovation Partners structurally different from a standalone venture fund?

MSIP is the internal commercialization and venture-investment division of the Mount Sinai Health System, not a third-party limited partnership. It invests directly from the health system's balance sheet, which eliminates the fixed fund-life horizon that governs most venture firms and allows it to hold positions through extended clinical-regulatory timelines. The office's portfolio companies also gain access to Mount Sinai's hospital network for clinical validation — a de-risking mechanism unavailable to startups funded by generalist venture firms.

### What kinds of assets does MSIP actually hold — equity, royalties, or both?

The office holds a mix of equity stakes in venture-backed spinouts, licensing royalties from technologies that are outlicensed to third parties, and revenue-sharing agreements tied to corporate research partnerships. When Mount Sinai faculty invent a new therapeutic, diagnostic, or digital-health platform, MSIP files patents through its in-house IP team and then determines whether commercialization should proceed via a royalty-bearing license to an existing company or a new equity-funded startup in which Mount Sinai retains a significant ownership position.

### Is Mount Sinai Innovation Partners open to external limited partners or co-investors?

MSIP does not operate a traditional venture fund open to external LP commitments. Its investment capital comes from the Mount Sinai Health System's balance sheet and research-related income. However, the office regularly syndicates individual spinout investment rounds to external venture firms and corporate strategic partners, making co-investment access available on a deal-by-deal basis. Detailed information on syndication criteria or minimum co-investment amounts is not publicly disclosed.

## Related profiles

- [Mountain Capital Management](https://altss.com/profile/mountain-capital-management)
- [Mozaik Investments](https://altss.com/profile/mozaik-investments)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/mount-sinai-innovation-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology